NCT03721978Phase 3Completed

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Study sponsor: Inovio Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-08-23Actual
Enrollment · participants203Actual
Source updated2024-10-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview